Fair Value Measurements (Tables)

9 Months Ended

Nov. 01, 2025

Fair Value Disclosures [Abstract]

Schedule of Fair Values of Financial Instruments

The fair value of the Company’s financial instruments are as follows:

($000)	November 1, 2025		February 1, 2025		November 2, 2024
Cash and cash equivalents (Level 1)	$	4,061,173	$	4,730,744	$	4,349,262
Restricted cash and cash equivalents (Level 1)	$	66,962	$	65,718	$	65,396

Schedule of Fair Value of Assets and Liabilities

The fair value measurement for funds with quoted market prices in active markets (Level 1) are as follows:

($000)	November 1, 2025		February 1, 2025		November 2, 2024
Nonqualified deferred compensation program (Level 1)	$	215,469	$	196,786	$	189,522